Literature DB >> 9793870

The effects of early and sustained intervention on the long-term morbidity of schizophrenia.

R J Wyatt1, I D Henter.   

Abstract

By examining the literature concerning early intervention with antipsychotic medications, and how it affects long-term morbidity, this article will review the concept that early intervention with antipsychotic medications improves the long-term course of schizophrenia. It also looks at the potential long-term effects of discontinuing antipsychotic medications early in the course of schizophrenia. It appears that early intervention with antipsychotic medications decreases some of the long-term morbidity associated with schizophrenia. Some of the implications of this finding are discussed in the context of both clinical practice and clinical research.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9793870      PMCID: PMC4308051          DOI: 10.1016/s0022-3956(97)00014-9

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  60 in total

1.  Decline in the diagnosis of schizophrenia among first contacts with psychiatric services in north-east Scotland, 1969-1984.

Authors:  J M Eagles; D Hunter; C McCance
Journal:  Br J Psychiatry       Date:  1988-06       Impact factor: 9.319

2.  The dopamine hypothesis: variations on a theme (II).

Authors:  R J Wyatt
Journal:  Psychopharmacol Bull       Date:  1986

3.  Decline in the diagnosis of schizophrenia among first admissions to Scottish mental hospitals from 1969-78.

Authors:  J M Eagles; L J Whalley
Journal:  Br J Psychiatry       Date:  1985-02       Impact factor: 9.319

Review 4.  Neuroleptics and the natural course of schizophrenia.

Authors:  R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

5.  The treatment of acute schizophrenia without drugs: an investigation of some current assumptions.

Authors:  W T Carpenter; T H McGlashan; J S Strauss
Journal:  Am J Psychiatry       Date:  1977-01       Impact factor: 18.112

6.  Are there schizophrenics for whom drugs may be unnecessary or contraindicated?

Authors:  M Rappaport; H K Hopkins; K Hall; T Belleza; J Silverman
Journal:  Int Pharmacopsychiatry       Date:  1978

7.  Evidence for a gender-specific decline in the rate of schizophrenia in rural Ireland over a 50-year period.

Authors:  J L Waddington; H A Youssef
Journal:  Br J Psychiatry       Date:  1994-02       Impact factor: 9.319

8.  Course of treatment response in first-episode and chronic schizophrenia.

Authors:  S R Szymanski; T D Cannon; F Gallacher; R J Erwin; R E Gur
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

9.  Why has the incidence of schizophrenia in Danish psychiatric institutions decreased since 1970?

Authors:  P Munk-Jørgensen
Journal:  Acta Psychiatr Scand       Date:  1987-01       Impact factor: 6.392

10.  Changing trends in first admissions and readmissions for mania and schizophrenia in New Zealand, 1974 to 1984.

Authors:  P R Joyce
Journal:  Aust N Z J Psychiatry       Date:  1987-03       Impact factor: 5.744

View more
  10 in total

Review 1.  Psychosis.

Authors:  Ernesto Ferran; Charles Barron; Teddy Chen
Journal:  West J Med       Date:  2002-09

2.  Point-counterpoint: the importance of "open access" to psychotropics for our patients.

Authors:  Alan D Schmetzer; John J Wernert
Journal:  Psychiatr Q       Date:  2006

3.  Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Authors:  Prakash S Masand; Miquel Roca; Martin S Turner; John M Kane
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

4.  Predictors of psychosis remission in psychotic disorders that co-occur with substance use.

Authors:  Carol L M Caton; Deborah S Hasin; Patrick E Shrout; Robert E Drake; Boanerges Dominguez; Sharon Samet; Bella Schanzer
Journal:  Schizophr Bull       Date:  2006-07-27       Impact factor: 9.306

5.  The long-term effects of placebo in patients with chronic schizophrenia.

Authors:  R J Wyatt; I D Henter; J J Bartko
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

6.  Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death.

Authors:  Ming-Chang Yang; For-Wey Lung
Journal:  Psychopharmacology (Berl)       Date:  2011-04-27       Impact factor: 4.530

7.  Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care.

Authors:  Raphael J. Leo; Paula Del Regno
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-12

8.  Multimodal Assessment of Schizophrenia and Depression Utilizing Video, Acoustic, Locomotor, Electroencephalographic, and Heart Rate Technology: Protocol for an Observational Study.

Authors:  Robert O Cotes; Mina Boazak; Emily Griner; Zifan Jiang; Bona Kim; Whitney Bremer; Salman Seyedi; Ali Bahrami Rad; Gari D Clifford
Journal:  JMIR Res Protoc       Date:  2022-07-13

Review 9.  Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.

Authors:  Lawrence H Yang; Bernalyn Ruiz; Amar D Mandavia; Margaux M Grivel; Liang Y Wong; Michael R Phillips; Matcheri S Keshavan; Huijun Li; Jeffrey A Lieberman; Ezra Susser; Larry J Seidman; William S Stone
Journal:  Schizophr Res       Date:  2020-04-05       Impact factor: 4.939

Review 10.  Treating early psychosis: who, what, and when?

Authors:  Barbara A Cornblatt; Andrea M Auther
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.